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Abstract
Background: D2-40 has been shown a selective marker for lymphatic endothelium, but also shown in the benign
cervical basal cells. However, the application of D2-40 immunoreactivity in the cervical basal cells for identifying the
grade of cervical intraepithelial neoplasia (CIN) has not been evaluated.
Methods: In this study, the immunoreactive patterns of D2-40, compared with p16
INK4A, which is currently
considered as the useful marker for cervical cancers and their precancerous diseases, were examined in total 125
cervical specimens including 32 of CIN1, 37 of CIN2, 35 of CIN3, and 21 of normal cervical tissue. D2-40 and
p16
INK4A immunoreactivities were scored semiquantitatively according to the intensity and/or extent of the
staining.
Results: Diffuse D2-40 expression with moderate-to-strong intensity was seen in all the normal cervical epithelia
(21/21, 100%) and similar pattern of D2-40 immunoreactivity with weak-to-strong intensity was observed in CIN1
(31/32, 97.2%). However, negative and/or focal D2-40 expression was found in CIN2 (negative: 20/37, 54.1%; focal:
16/37, 43.2%) and CIN3 (negative: 22/35, 62.8%; focal: 12/35, 34.3%). On the other hand, diffuse immunostaining for
p16
INK4A was shown in 37.5% of CIN1, 64.9% of CIN2, and 80.0% of CIN3. However, the immunoreactive pattern of
D2-40 was not associated with the p16
INK4A immunoreactivity.
Conclusions: Immunohistochemical analysis of D2-40 combined with p16
INK4A may have a significant implication
in clinical practice for better identifying the grade of cervical intraepithelial neoplasia, especially for distinguishing
CIN1 from CIN2/3.
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Background
Although the histological assessment of cervical biopsies
is often considered as the “gold standard”, evaluating
the grade of cervical intraepithelial neoplasia (CIN) by
conventional light microscopy, especially distinguishing
CNI1 from CIN2/3, often presents a diagnostic issue in
surgical pathology [1]. There has been much recent
attention regarding use of p16 immunoreactivity for the
detection of high grade cervical squamous lesions, how-
ever, assessment of its clinical applications is seriously
hampered by lack of standardized methodology [2].
Novel markers are needed to apply on histological speci-
mens to identify the grade of cervical intraepithelial neo-
plasia when the lesion is morphologically difficult to
assess, especially between CIN1 and CIN2/3.
D2-40 is a recently developed, commercially available
monoclonal antibody directed against M2A antigen, a
Mr 40 000 surface sialoglycoprotein originally detected
in association with germ cell neoplasia and fetal testicu-
lar gonocytes [3]. Since D2-40 has also been demon-
strated selective immunoreactivity for lymphatic
endothelium [4], its proposed clinical uses include
demonstration of lymphatic invasion by primary tumors
and its use as a marker of certain vascular lesions [5,6].
Besides the above, the D2-40 immunostaining has been
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the uterine cervix and benign cervical squamous epithe-
lia [8].
p16
INK4A is currently used as a ‘positive’ immunohis-
tochemical marker for CIN, which is proposed to aid
the identification of high-grade cervical lesions [9]. To
evaluate the use of D2-40 in helping the diagnosis of
CIN, we performed immunoreactivity of D2-40, com-
pared to p16
INK4A, on cervical specimens to aid a better
identification of grade of CIN.
Materials and methods
Clinical specimens
Cases were retrieved from the files of the Departments
of Pathology in Shanghai Jiaotong University and Tongji
University. This study consisted of 125 cases of CIN1 (n
= 32), CIN2 (n = 37), CIN3 (n = 35) and normal cervi-
cal tissue (n = 21). The consensus diagnosis was con-
firmed by an expert pathology panel when inter-
observer variability in grading CIN based solely on
H&E-stained slides occurred. One representative paraf-
fin block from each case was used for the study.
Immunohistochemistry
Immunohistochemical assays were performed on for-
malin-fixed paraffin-embedded tissues. Sections (5 μm
thick) were cut and deparaffinized in xylene and rehy-
drated in graded alcohols. Slides were boiled in citrate
buffer (pH 6.0) at 95 ~ 100°C for 5 min and were
cooled down for 20 min. Endogenous peroxide was
blocked by 3% hydrogen peroxide in methanol for 10
min. Sections were incubated with D2-40 monoclonal
antibody (1:200, DAKO, Carpinteria, CA, USA) and
monoclonal anti-p16
INK4A antibody (clone G175-405,
DAKO, Carpinteria, CA, USA) for 1 h at 37°C.
Immunohistochemical staining was performed using
EnVision + HRP DAB system (DAKOCytomation, Car-
pinteria, CA, USA). All sections were counterstained
with Meyer’s Hematoxylin. The sections processed
without the primary antibodies were used as negative
control.
Immunohistochemical evaluation
Immunohistochemical D2-40 reactivity was evaluated as
the cytoplasmic staining in basal cells of squamous
epithelium. D2-40 expression was scored semiquantita-
tively as previously describ e d[ 8 ]a sf o l l o w s :( - ) ,0 %o f
immunoreative cells; (+), <5% of immunoreactive cells
with weak staining; (++), 5 ~ 50% of immunoreactive
cells with weak to moderate staining; (+++), >50% of
immunoreactive cells with moderate to strong staining.
The pattern of D2-40 expression was evaluated as fol-
lows: negative (-); focal expression (+ ~ ++): diffuse
expression (+++). p16
INK4A expression was evaluated
according to the criteria previously established by Klaes
et al [10] as follows: negative (<1% of the cells were
positive); focal expression (isolated cells or small cell
clusters, but <25% of the cells were positive); diffuse
expression (>25% of the cells were positive).
Two investigators evaluated the specimens indepen-
dently on separated counts. The results from the two
investigators were highly correlated (r > 0.85 for all
counts). Calculations were therefore done using averages
of the two sets of counts.
Statistical analysis
Data were presented as absolute numbers and percen-
tages. c
2-test for nominal data was used to compare
baseline characteristics. Reported P-values < 0.05 were
considered as significant.
Results
D2-40 protein was expressed in cytoplasm of the basal
cells of squamous epithelium (SE) as well as in the
epithelial cells of lymphatic vessels in the cervical
stroma (Figure 1). Diffuse expression of D2-40 with
moderate-to-strong staining intensity was seen in the
basal cells of all the normal cervical tissues (21/21,
100%), and similar pattern of D2-40 expression was
shown in CIN1 (diffuse: 31/32, 97.2%). However, nega-
tive and/or focal expression of D2-40 was found in
CIN2 (negative: 20/37, 54.1%; focal: 16/37, 43.2%) and
CIN3 (negative: 22/35, 62.8%; focal: 12/35, 34.3%). Sig-
nificant difference in D2-40 expression was observed
between CIN1 and CIN2/3 (p < 0.01), while no signifi-
cant difference in D2-40 expression was observed
between normal cervix and CIN1, and between CIN2
and CIN3 (Table 1).
Twenty-one cases of normal cervical tissue did not
show any immunoreactivity for p16
INK4A, meanwhile,
dysplastic epithelium showed cytoplasmic and/or
nuclear staining for p16
INK4A in 98.1% (102/104) of
CIN. There was a grade-dependent fashion of diffuse
p16
INK4A immunostaining shown in 37.5% of CIN1,
64.9% of CIN2 and 80% of CIN3 (Table 2). Diffuse
p16
INK4A immunostaining was often restricted to the
lower third of the cervical epithelium in CIN1 and more
than a third/full thickness of the cervical epithelium in
CIN2/3 (Figure 2).
Diffuse and focal/negative immunostaining of D2-40
correspond to CIN1 (31/32) and CIN2/3 (70/72),
accordingly. In contrast, increased diffuse immunostain-
ing compared to decreased focal immunostaining of
p16
INK4A was associated with higher grade of CIN.
However, not only the present of D2-40 in CIN1 was
not associated with p16
INK4A negativity or non-block
positivity, but also the loss of D2-40 in CIN2/3 was not
associated with block positivity for p16
INK4A.
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Histological evaluation remains a basis for treatment
and follow-up of women with CIN. The fundamental
premise for treating or following young women with
CIN hinges on the risk of CIN2 or CIN3 for which cone
biopsy or LEEP will be required. Hence, helpful biologi-
cal markers are in need of distinguishing CIN1 from
CIN2/3 when the diagnosis is not certain, particularly in
young women.
The monoclonal antibody D2-40 was described to
react with a novel oncofetal membrane antigen M2A,
presenting on fetal gonocytes, intratubular germ-cell
neoplasia and seminoma cells [11]. The M2A antigen
has also been shown as a developmental marker for
human Sertoli cells, presenting on immature Sertoli
cells until puberty, and loosing during their transition to
am a t u r ea d u l tp h e n o t y p e[ 1 2 ] .W ef o u n dt h a tD 2 - 4 0
immunoreactivity was observed exclusively in the basal
cell layer of the cervical squamous epithelium, which
agrees with the previous study [8]. Taken together, D2-
40 protein expression may be predominantly associated
with immaturity. D2-40 has been served as a new selec-
tive marker for lymphatic endothelium, and used in
identifying the presence of lymphatic invasion in various
Table 1 The expression of D2-40 in the cervical
intraepithelial neoplasia (CIN)
D2-40 expression (%)
Lesion type n negative focal diffuse Positivity
Normal cervix 21 0 (0) 0 (0) 21 (100%) 100%
CIN 1 32 0 (0) 1(2.8%) 31 (97.2%) 100%
CIN 2 37 20 (54.1%) 16 (43.2%) 1 (2.7%) 45.9%
CIN 3 35 22 (62.8%) 12 (34.3%) 1 (2.9%) 37.1%
Table 2 The expression of p16
INK4A in the cervical
intraepithelial neoplasia (CIN)
p16
INK4A expression (%)
Lesion type n negative focal diffuse Positivity
Normal cervix 21 21 (100%) 0 (0) 0 (0) 0
CIN 1 32 2 (6.2%) 18 (56.3%) 12 (37.5%) 93.8%
CIN 2 37 0 (0) 13 (35.1%) 24 (64.9%) 100%
CIN 3 35 0 (0) 7 (20.0%) 28 (80.0%) 100%
C
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Figure 1 The expression of D2-40 in the normal cervical tissue and CIN. The D2-40 immunoreactivity was localized to the basal cell layer as
well as the endothelial cells of lymphatic vessels indicated by arrow. A: diffuse expression of D2-40 in the basal cells of squamous epithelium in
the normal cervical tissue. B: diffuse expression of D2-40 in the basal cells of squamous epithelium in CIN1 on the right and foal expression of
D2-40 in the basal cells of squamous epithelium in CIN2 on the left. C: negative expression of D2-40 in CIN2. D: negative expression of D2-40 in
CIN3 in the middle and diffuse expression of D2-40 in the basal cells of squamous epithelium in the normal cervical tissue indicated by arrow.
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as well as cervical neoplasia [13]. The D2-40 immunor-
eactivity observed in the lymphatic endothelium of the
cervical stroma in this study acts as an internal control,
indicating that the loss of D2-40 protein expression in
the squamous epithelium in CIN2/3 specimens is not a
false negative pattern arising from fixation or processing
issues. Furthermore, this study expanded the informa-
tion that the decreased expression of D2-40 in the basal
cells of SE correlates the grade of CIN, especially show-
ing the significant difference between CIN1 and CIN2/3.
Likewise, low D2-40 immunoreactivity correlates with
lymphatic invasion and nodal metastasis in early-stage
squamous cell carcinoma of the uterine cervix [8], and
D2-40 positivity in tumor cells is associated with a bet-
ter prognosis in ASC [13]. Thus, the D2-40 protein may
be a better prognostic marker in cervical lesion. That
might be associated with the M2A, recognized by the
D2-40 antibody. Although its function is yet unclear, it
contains one of the mucin-type glycoproteins that are
expressed on human normal cells and tumors [14,15].
Mucins are large, highly glycosylated proteins recog-
nized by their tandem repeat domains, first as compo-
nents of cell surfaces, and later for their roles in the
protection of epithelia and other cells [16,17].
In the current study, we also compared the D2-40
immunoreactivity to p16
INK4A, identified as a biomarker
for transforming human papillomavirus (HPV) infec-
tions. Increased cases with diffuse immunostaining of
p16
INK4A occurred in the higher grade of CIN (CIN2/3),
which is in agreement with the previous studies [18-20].
In addition, several studies suggest an improved diag-
nostic accuracy for diagnosing CIN lesions with the dif-
fuse p16
INK4A immunoreactivity [21,22]. Although there
is good evidence that diffuse p16
INK4A immunostaining
correlates with the severity of CIN, we have to take into
B
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Figure 2 Representative examples of p16
INK4A immunoreactive patterns in the normal cervical tissue and CIN.A :f o c a lp 1 6
INK4A
immunostaining in CIN1. B: diffuse p16
INK4A immunostaining restricted to the lower third of the cervical epithelium in CIN1. C: diffuse p16
INK4A
immunostaining of more than a third of the cervical epithelium in CIN2 on the left and negative p16
INK4A immunostaining in the normal cervical
tissue on the right. D: diffuse p16
INK4A immunostaining of full thickness of the cervical epithelium in CIN3.
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INK4A immu-
noreactivity. Because the focal staining was seen in
more than a half of CIN1 cases, but this pattern was
also seen in some CIN2/3 cases. Thus, an additional
ideal biomarker needs to be explored. This study shows
that the immunoreactive pattern of D2-40 was more
specific than that of p16
INK4A immunoreactivity when
distinguishing CIN1 from CIN2/3 because diffuse and
focal/negative immunostaining of D2-40 predominantly
presents in CIN1 and CIN2/3, respectively. No correla-
tion between D2-40 and p16
INK4A immunoreactity was
found, which might be due to p16
INK4A associated with
transforming HPV infections, but not D2-40. Although
no correlation between D2-40 and p16
INK4A immunor-
eactity was shown, the data in the current study indicate
that the combined use of D2-40 and p16
INK4A immu-
noreactivities in routine histopathology would improve
accuracy of diagnosis of CIN.
Conclusions
D2-40 may be a helpful marker for distinguishing CIN1
from CIN2/3 in pathological practice.
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